AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29947099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 939
Study 29947099 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 939
Study 29947099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin regimens
Number of subjects: 939
Study 27362794 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating microRNAs
Number of subjects: 160
Study 27362794 — intervention group
Group type: EXPERIMENTAL
Intervention: FEV1/FVC microRNAs
Number of subjects: 160
Study 27362794 — intervention group
Group type: EXPERIMENTAL
Intervention: Ontology analyses
Number of subjects: 160
Study 25602143 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT); 3 bouts/week of 4-8 30-s cycle sprints with 4-min recovery for 6 weeks
Number of subjects: 47
Study 25602143 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control condition (CON)
Number of subjects: 47
Study 22261127 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO(4)) discontinued after 6 hours postpartum
Number of subjects: 150
Study 22261127 — intervention group
Group type: COMPARATOR
Intervention: Magnesium sulfate (MgSO(4)) continued for 24 hours postpartum
Number of subjects: 150
Study 19965915 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe (10 mg/d)
Number of subjects: 215
Study 19965915 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin (10 mg/d)
Number of subjects: 215
Study 19965915 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe + simvastatin
Number of subjects: 215
Study 19965915 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (ezetimibe + simvastatin)
Number of subjects: 215
Study 19965915 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe
Number of subjects: 215
Study 18340009 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/d fluvastatin
Number of subjects: 37
Study 18340009 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/d atorvastatin
Number of subjects: 37
Study 18340009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 16007894 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (RT)
Number of subjects: 0
Study 16007894 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam RT in association with androgen suppression
Number of subjects: 0
Study 16007894 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam RT as a postoperative adjunct
Number of subjects: 0
Study 12429759 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy with three treatments of 2000 pulses each and a positive energy flux density (ED+) of 0.07 to 0.09 mJ/mm²
Number of subjects: 272
Study 12429759 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 272
Study 12429759 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shock wave therapy and Placebo therapy
Number of subjects: 272
Study 9564925 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter irrigation
Number of subjects: 25
Study 9564925 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle flap closure
Number of subjects: 25
Study 9564925 — intervention group
Group type: COMPARATOR
Intervention: Catheter irrigation (successful)
Number of subjects: 25
Study 9564925 — intervention group
Group type: COMPARATOR
Intervention: Catheter irrigation (unsuccessful)
Number of subjects: 25
Study 9564925 — intervention group
Group type: COMPARATOR
Intervention: Muscle flap closure (primary)
Number of subjects: 25
Study 7826828 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 2.5 mg day-1
Number of subjects: 431
Study 7826828 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 5 mg day-1
Number of subjects: 431
Study 7826828 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 10 mg day-1
Number of subjects: 431
Study 7826828 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg day-1
Number of subjects: 431
Study 7826828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 431
Study 2901122 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg once daily)
Number of subjects: 12
Study 2901122 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once daily)
Number of subjects: 12
Study 2901122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29633389 — intervention group
Group type: EXPERIMENTAL
Intervention: SOF + NS5A without RBV for 12 weeks (156 patients)
Number of subjects: 512
Study 29633389 — intervention group
Group type: EXPERIMENTAL
Intervention: SOF + NS5A without RBV for 24 weeks (239 patients)
Number of subjects: 512
Study 29633389 — intervention group
Group type: EXPERIMENTAL
Intervention: SOF + NS5A + RBV for 12 weeks (47 patients)
Number of subjects: 512
Study 29633389 — intervention group
Group type: EXPERIMENTAL
Intervention: SOF + NS5A + RBV for 24 weeks (70 patients)
Number of subjects: 512
Study 29633389 — intervention group
Group type: COMPARATOR
Intervention: RBV group (adverse events)
Number of subjects: 512
Study 27072153 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Six-hour nurse-led interactive group education programme
Number of subjects: 156
Study 27072153 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - Standard information
Number of subjects: 156
Study 25748084 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomedical educational text
Number of subjects: 130
Study 25748084 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial educational text
Number of subjects: 130
Study 25748084 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio‐psychosocial educational text
Number of subjects: 130
Study 25748084 — intervention group
Group type: COMPARATOR
Intervention: Baseline assessment
Number of subjects: 130
Study 23827820 — intervention group
Group type: EXPERIMENTAL
Intervention: Jitai tablets (JTT)
Number of subjects: 386
Study 23827820 — intervention group
Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 386
Study 20629478 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy interventions (including low lactose intake) in children and adult women
Number of subjects: 223336
Study 20629478 — intervention group
Group type: COMPARATOR
Intervention: Lactose doses of 0-2 grams (lactose-reduced solution/milk)
Number of subjects: 223336
Study 20629478 — intervention group
Group type: COMPARATOR
Intervention: Probiotics
Number of subjects: 223336
Study 20629478 — intervention group
Group type: COMPARATOR
Intervention: Colonic adaptation
Number of subjects: 223336
Study 20629478 — intervention group
Group type: COMPARATOR
Intervention: Varying lactose doses
Number of subjects: 223336
Study 20629478 — intervention group
Group type: COMPARATOR
Intervention: Other agents (not specified)
Number of subjects: 223336
Study 20629478 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose doses of 12-15 grams
Number of subjects: 223336
Study 20629478 — intervention group
Group type: COMPARATOR
Intervention: Lactose doses above 12 grams
Number of subjects: 223336
Study 18652862 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate low-fat (LCLF) diet
Number of subjects: 71
Study 18652862 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate low-fat (HCLF) diet
Number of subjects: 71
Study 18652862 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate high-fat (LCHF) diet
Number of subjects: 71
Study 18652862 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 71
Study 17132757 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone plus exercise (Group 1)
Number of subjects: 70
Study 17132757 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone plus no exercise (Group 2)
Number of subjects: 70
Study 17132757 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus exercise (Group 3)
Number of subjects: 70
Study 17132757 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus no exercise (Group 4)
Number of subjects: 70
Study 12970727 — intervention group
Group type: EXPERIMENTAL
Intervention: Entonox (nitrous oxide)
Number of subjects: 50
Study 12970727 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 50
Study 10743444 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 60
Study 10743444 — intervention group
Group type: COMPARATOR
Intervention: 0.2% bupivacaine
Number of subjects: 60
Study 9111824 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% shampoo
Number of subjects: 20
Study 8113481 — intervention group
Group type: COMPARATOR
Intervention: Standard Behavioral Treatment (SBT)
Number of subjects: 202
Study 8113481 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT plus food provision
Number of subjects: 202
Study 8113481 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT plus incentives
Number of subjects: 202
Study 8113481 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT plus food provision and incentives
Number of subjects: 202
Study 3945045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (80 mg Fe++ three times daily) for 6 weeks
Number of subjects: 32
Study 3945045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no iron therapy)
Number of subjects: 32
Study 30215785 — intervention group
Group type: EXPERIMENTAL
Intervention: 21‐mg nicotine patch for 24 weeks with behavior counseling
Number of subjects: 525
Study 30215785 — intervention group
Group type: EXPERIMENTAL
Intervention: 21‐mg nicotine patch for 8 weeks with behavior counseling
Number of subjects: 525
Study 30215785 — intervention group
Group type: EXPERIMENTAL
Intervention: 21‐mg nicotine patch for 52 weeks with behavior counseling
Number of subjects: 525
Study 30117915 — intervention group
Group type: EXPERIMENTAL
Intervention: Deformable mirror technology
Number of subjects: 0
Study 30117915 — intervention group
Group type: COMPARATOR
Intervention: Moving diffuser
Number of subjects: 0
Study 27768194 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids plus ReadMyQuips training
Number of subjects: 24
Study 27768194 — intervention group
Group type: COMPARATOR
Intervention: Hearing aids only
Number of subjects: 24
Study 24572255 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-only intervention (group 2)
Number of subjects: 114
Study 24572255 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer with interactive website (group 3)
Number of subjects: 114
Study 24572255 — intervention group
Group type: COMPARATOR
Intervention: No intervention (group 1)
Number of subjects: 114
Study 24572255 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving ≥20 min/day in MPA bouts
Number of subjects: 114
Study 24572255 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving ≥10 000 steps/day or ≥30 min/day of MPA
Number of subjects: 114
Study 24572255 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular stiffness
Number of subjects: 114
Study 24498697 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counselling (n=8)
Number of subjects: 17
Study 24498697 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (n=9)
Number of subjects: 17
Study 24498697 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial counselling sessions before physical intervention
Number of subjects: 17
Study 20027108 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intravenous rolofylline, 4-hour infusions once daily for 4 consecutive days
Number of subjects: 19
Study 20027108 — intervention group
Group type: COMPARATOR
Intervention: Single oral dose of midazolam 7.5 mg
Number of subjects: 19
Study 20027108 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intravenous rolofylline
Number of subjects: 19
Study 19071974 — intervention group
Group type: EXPERIMENTAL
Intervention: Antismoking public service announcement (PSA) viewed at least once
Number of subjects: 0
Study 16148457 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 20
Study 16148457 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 20
Study 16148457 — intervention group
Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 20
Study 12736829 — intervention group
Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 10
Study 12736829 — intervention group
Group type: COMPARATOR
Intervention: Cycling
Number of subjects: 10
Study 10586391 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (IV infusion)
Number of subjects: 18
Study 10586391 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin (IV infusion)
Number of subjects: 18
Study 8704896 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Start breast-feeding education program
Number of subjects: 90
Study 1914373 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral nifedipine
Number of subjects: 13
Study 1914373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 7017370 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal intensive care
Number of subjects: 410
Study 31838028 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaferon for children (AC)
Number of subjects: 0
Study 31838028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30461405 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed telecoil
Number of subjects: 20
Study 30461405 — intervention group
Group type: COMPARATOR
Intervention: Default telecoil
Number of subjects: 20
Study 28368681 — intervention group
Group type: EXPERIMENTAL
Intervention: Readiness to Change (RTC)
Number of subjects: 194
Study 28368681 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (moderator)
Number of subjects: 194
Study 26916738 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led palliative care intervention
Number of subjects: 30
Study 26916738 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 30
Study 23879234 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MMF) 0.1% ointment for 12 weeks
Number of subjects: 147
Study 21878580 — intervention group
Group type: EXPERIMENTAL
Intervention: Se+highI (100 μg selenium + >50 mg iodine as iodate/day for 8 weeks)
Number of subjects: 143
Study 21878580 — intervention group
Group type: EXPERIMENTAL
Intervention: highI (>50 mg iodine as iodate/day for 8 weeks)
Number of subjects: 143
Study 21878580 — intervention group
Group type: EXPERIMENTAL
Intervention: Se+lowI (80 μg iodine as iodate/day + selenium)
Number of subjects: 143
Study 21878580 — intervention group
Group type: EXPERIMENTAL
Intervention: Se+ (selenium alone)
Number of subjects: 143
Study 21878580 — intervention group
Group type: EXPERIMENTAL
Intervention: lowI (80 μg iodine as iodate/day without selenium)
Number of subjects: 143
Study 21878580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 18645345 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion (0.5-3 microg/kg/min)
Number of subjects: 30
Study 18645345 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (7.5 microg/kg/min)
Number of subjects: 30
Study 18645345 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (7.5 microg/kg/min) plus dopamine (0.5-3 microg/kg/min)
Number of subjects: 30
Study 18645345 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide and dopamine
Number of subjects: 30
Study 17135607 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RX) for 6 months
Number of subjects: 49
Study 17135607 — intervention group
Group type: COMPARATOR
Intervention: Control non-exercise group
Number of subjects: 49
Study 12973291 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid 50% at original pH
Number of subjects: 50
Study 12973291 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid 25% at original pH
Number of subjects: 50
Study 12973291 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid 10% at original pH
Number of subjects: 50
Study 12973291 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid 5% at original pH
Number of subjects: 50
Study 12973291 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid buffered to pH 6
Number of subjects: 50
Study 12973291 — intervention group
Group type: COMPARATOR
Intervention: Bidistilled water
Number of subjects: 50
Study 12973291 — intervention group
Group type: COMPARATOR
Intervention: Sodium hypochlorite (NaOCl)
Number of subjects: 50
Study 10735695 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin (Trasylol)
Number of subjects: 60
Study 8655886 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (200 micrograms once daily)
Number of subjects: 348
Study 8655886 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine tablets (60 mg twice daily)
Number of subjects: 348
Study 8655886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 348
Study 1419105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron plus dexamethasone
Number of subjects: 47
Study 1419105 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron plus dexamethasone
Number of subjects: 47
Study 3966746 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial amplitude of ventricular fibrillation (average 0.55 +/- 0.25 mV)
Number of subjects: 394
Study 3966746 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine ventricular fibrillation (0.2 mV or less)
Number of subjects: 394
Study 3966746 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay in initiation of treatment
Number of subjects: 394
Study 31747018 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenient rate control
Number of subjects: 614
Study 31747018 — intervention group
Group type: COMPARATOR
Intervention: Strict rate control
Number of subjects: 614
Study 31747018 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 614
Study 31747018 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 614
Study 30917302 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% benzydamine hydrochloride (Tantum Verde®) mouthwash solution
Number of subjects: 39
Study 30917302 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 39
Study 28195990 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, multicomponent, adapted exercise program (approximately 20 weeks)
Number of subjects: 0
Study 28195990 — intervention group
Group type: COMPARATOR
Intervention: Sedentary women
Number of subjects: 0
Study 28195990 — intervention group
Group type: COMPARATOR
Intervention: Active women
Number of subjects: 0
Study 26271204 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC (vincristine, adriamycin, cyclophosphamide)
Number of subjects: 856
Study 26271204 — intervention group
Group type: COMPARATOR
Intervention: VAI (vincristine, adriamycin, ifosfamide)
Number of subjects: 856
Study 26271204 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC
Number of subjects: 856
Study 26271204 — intervention group
Group type: COMPARATOR
Intervention: VAI
Number of subjects: 856
Study 23241227 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab monotherapy
Number of subjects: 44
Study 23241227 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Ranibizumab + PDT)
Number of subjects: 44
Study 23241227 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 44
Study 21496998 — intervention group
Group type: EXPERIMENTAL
Intervention: Hilotherm cooling therapy
Number of subjects: 30
Study 21496998 — intervention group
Group type: COMPARATOR
Intervention: Conventional cooling with cooling compresses
Number of subjects: 30
Study 19085267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sedating H1 antihistamine and non‐sedating H1 antihistamine (Group A)
Number of subjects: 120
Study 19085267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of H1 antihistamine and H2 antihistamine (Group B)
Number of subjects: 120
Study 19085267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of H1 antihistamine and leukotriene receptor antagonist (LRA) (Group C)
Number of subjects: 120
Study 19085267 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo medication (Group D)
Number of subjects: 120
Study 17018229 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy performed by nurses
Number of subjects: 4128
Study 17018229 — intervention group
Group type: COMPARATOR
Intervention: Endoscopy performed by doctors
Number of subjects: 4128
Study 14630840 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alendronate at a dose of 10 mg/day for six months
Number of subjects: 96
Study 14630840 — intervention group
Group type: COMPARATOR
Intervention: Control group (no alendronate)
Number of subjects: 96
Study 10832506 — intervention group
Group type: EXPERIMENTAL
Intervention: Sahaja Yoga meditation twice daily for 6 months
Number of subjects: 32
Study 10832506 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural exercises mimicking meditation for 6 months
Number of subjects: 32
Study 10832506 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 9106568 — intervention group
Group type: EXPERIMENTAL
Intervention: RIP waveforms (VRIP.BP(t) and VRIP.PNT(t))
Number of subjects: 11
Study 1551954 — intervention group
Group type: EXPERIMENTAL
Intervention: Short 3 day regimen of leuprolide acetate
Number of subjects: 0
Study 1551954 — intervention group
Group type: COMPARATOR
Intervention: Long-term leuprolide acetate
Number of subjects: 0
Study 2951793 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (100, 200, 400, 800, 1600 micrograms)
Number of subjects: 9
Study 2951793 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40, 80, 160, 320, 640 micrograms)
Number of subjects: 9
Study 2951793 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent (100 micrograms fenoterol + 40 micrograms ipratropium bromide)
Number of subjects: 9
Study 2951793 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of fenoterol and ipratropium bromide (Duovent)
Number of subjects: 9
Study 2951793 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 9
Study 29298506 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of the stapes head only (Group 2b)
Number of subjects: 145
Study 29298506 — intervention group
Group type: COMPARATOR
Intervention: Removal of the entire stapes superstructure (Group 1b)
Number of subjects: 145